GondolaBio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Joint Venture
- Latest Deal Amount
-
$300M
- Investors
-
7
GondolaBio General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to develop therapeutics for patients living with genetic diseases. The company aims to leverage biological research to create medicines addressing high unmet needs across multiple therapeutic areas, modalities, and stages, ranging from early discovery to clinical development, enabling the healthcare industry to treat, manage, and address rare genetic conditions.
Contact Information
Website
www.gondolabio.comCorporate Office
- 3160 Porter Drive
- Suite 250
- Palo Alto, CA 94304
- United States
Corporate Office
- 3160 Porter Drive
- Suite 250
- Palo Alto, CA 94304
- United States
GondolaBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Joint Venture | 16-Aug-2024 | $300M | Completed | Clinical Trials - Phase 2 |
GondolaBio Signals
GondolaBio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aisling Capital | Venture Capital | Minority | ||
| BridgeBio Pharma | Corporation | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Majority | ||
| Patient Square Capital | PE/Buyout | Minority |
GondolaBio FAQs
-
When was GondolaBio founded?
GondolaBio was founded in 2024.
-
Where is GondolaBio headquartered?
GondolaBio is headquartered in Palo Alto, CA.
-
What is the size of GondolaBio?
GondolaBio has 45 total employees.
-
What industry is GondolaBio in?
GondolaBio’s primary industry is Drug Discovery.
-
Is GondolaBio a private or public company?
GondolaBio is a Private company.
-
What is the current valuation of GondolaBio?
The current valuation of GondolaBio is .
-
What is GondolaBio’s current revenue?
The current revenue for GondolaBio is .
-
How much funding has GondolaBio raised over time?
GondolaBio has raised $300M.
-
Who are GondolaBio’s investors?
Aisling Capital, BridgeBio Pharma, Cormorant Asset Management, Frazier Healthcare Partners, and Patient Square Capital are 5 of 7 investors who have invested in GondolaBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process